First Horizon Corporation’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.3M Sell
65,698
-2,156
-3% -$284K 0.32% 87
2026
Q1
$9.46M Sell
67,854
-3,199
-5% -$448K 0.4% 80
2025
Q4
$8.72M Sell
71,053
-1,187
-2% -$144K 0.39% 82
2025
Q3
$8.02M Buy
+72,240
New +$8.21M 0.38% 85
2021
Q2
$241K Sell
3,506
-8
-0.2% -$534 0.02% 212
2021
Q1
$227K Sell
3,514
-148
-4% -$9.54K 0.02% 220
2020
Q4
$213K Buy
3,662
+39
+1% +$2.35K 0.02% 217
2020
Q3
$228K Buy
+3,623
New +$251K 0.02% 199
2013
Q2
$3.08M Buy
+60,072
New +$3.13M 0.84% 23

Other funds holding GILD

First Horizon Corporation's GILD Position: Q2 2026 in Review

First Horizon Corporation reduced its Gilead Sciences (GILD) stake by 3.2% in Q2 2026, selling an estimated $284K and leaving 65,698 shares worth $8.3M. The position accounts for 0.32% of the portfolio, ranked #87.

First Horizon Corporation first reported a position in GILD in Q2 2013 and has held it in 9 quarters since. The position peaked at $9.46M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • First Horizon Corporation held 65,698 shares of Gilead Sciences worth $8.3M as of Q2 2026.
  • First Horizon Corporation sold 2,156 Gilead Sciences shares in Q2 2026, an estimated $284K.
  • Gilead Sciences made up 0.32% of First Horizon Corporation's portfolio in Q2 2026, its #87 holding.
  • First Horizon Corporation first reported a position in Gilead Sciences in Q2 2013 and has held it in 9 quarters since.
  • First Horizon Corporation's Gilead Sciences position peaked at $9.46M in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.